Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Casino Group becomes PLESIO
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Crypto News: Pepeto Announces Its 160% APY Staking Stays Live While the Solana Price Prediction Targets $2,744
-
Sabre Cybersecurity Warns Ohio Businesses That Ransomware Attacks Strike When Nobody Is Watching
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Sword Appoints Dr. Adam Wolfberg as Chief Medical Officer
-
Budget 2026: Gold, Tax and What Investors Need to Know - Solomon Global
-
BUREAU VERITAS - Disclosure of treasury shares transactions carried out from October 12 to October 16, 2026
-
Heineken® teams up with Amazon to launch "Pubscription"... The world’s first streaming service for nights out
-
Heineken® teams up with Amazon to launch "Pubscription"... The world’s first streaming service for nights out
-
Zhihu Inc. Announces Results of the Extraordinary General Meeting
-
Sutherland and FlowX.AI Partner to Deliver Enterprise-Grade AI Solutions for Complex, Regulated Industries
-
LetPot Expands U.S. Retail Presence With Launch on TractorSupply.com
-
Future Travel Starts Now: 2026 JETOUR Global Technology Experience Day Kicks Off
-
BlackRock® Canada Announces October Cash Distributions for the iShares® ETFs
-
PONY AI Inc. to Report Third Quarter 2026 Financial Results on November 18, 2026
-
KFSH Brings Cardiac Catheterization Directly to Emergency Department to Accelerate Critical Care
-
Fortuna intersects 0.96 g/t gold over 350 meters at the Lindero Mine, Argentina
-
Orikine Presents Preclinical Data Demonstrating Sustained Myeloid Reprogramming and Disease Control with ORK1 in Inflammatory Bowel Disease at UEG Week 2026
-
Maxion Therapeutics Appoints Biopharma Leader Mikael Dolsten to Board of Directors
-
Form 8.3 - Gamma Communications plc
-
Aqua free expands its product portfolio: New Baclyser® neo T Max offers greater capacity and efficiency
-
LEPAS’s First Global Concept Car Set for World Premiere During Global Elegant Lifestyle Week, Unveiling Next-Generation Leopard Aesthetics
-
Hesai Group to Report Third Quarter 2026 Financial Results on Tuesday, November 10, 2026
-
Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 19 10 2026] - (CGWL)
-
Form 8.3 - STHREE PLC
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
VR Receives NOI Permit with Expanded Drill Site Coverage for its New Boston Moly-Copper-Tungsten- Silver Porphyry Project in Nevada
-
Roamly Appoints Christine Franzi as Head of Insurance Programs
-
Transactions in connection with share buy-back program
-
A Natural Wonder at the Liaohe Estuary Wetland: Panjin's Red Beach Welcomes Its Golden Autumn Viewing Season
-
A Natural Wonder at the Liaohe Estuary Wetland: Panjin's Red Beach Welcomes Its Golden Autumn Viewing Season
-
Water shortages will threaten growth within five years, say over half of European industrial leaders
-
Gesynta Pharma completes enrollment in Phase 2 NOVA trial evaluating vipoglanstat in endometriosis
-
Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Tryg Forsikring A/S mandates Tier 2 Capital Notes transaction
-
How Zhengzhou Marathon turns race into journey through Chinese civilization
-
AltruBio Presents Phase 2a Data of ALTB-268 in Advanced Therapy-Refractory Ulcerative Colitis at UEG Week 2026
-
VINCI wins a contract for a data center in the Iberian Peninsula
-
Quadient Named a Leader in the 2026 IDC MarketScape for Worldwide Intelligent Customer Communication Management
-
Steinmann Haustechnik AG, based in Central Switzerland, becomes part of InstallatørGruppen
-
Investor Webinar Via Investor Meet Company
-
ARGAN: Availability of the Merger Auditor’s Report
-
Equinor ASA: Share buy-back – third tranche for 2026
-
Equinor ASA: Buy-back of shares to share programmes for employees
-
Ambrose Healthcare Acquires AM-Pharma for Up to €161 Million, Expanding its Rare Disease Pipeline and Gaining a European Base
-
OSB GROUP PLC - Transaction in Own Shares
